Showing 48 results

Award of EU-FP7 funding to Alkion BioPharma as part of TriForC consortium working on the commercialization of terpenoids

Companies House incorporation of Neuroprotexeon Limited

Webcapture from a recent training course (Nov 2020) held at the EBI (European Institute of Bioinformatics) that includes Phyre – open to academia and industry

Phyre identified as a resource within ELIXIR UK node servies

Environmental Impact Assessment for expanding Congonhas Airport

Partnerships with Neuroprotexeon

The new national action plan for the amphibians of Madagascar. English version

Environmental Impact Assessment for landfill expansion

Industry press release on sale of Alkion Biopharma to Evonik

Press release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product

Phyre identified as a resource on ExPASy

Norwegian Assessment of the risk to Norwegian biodiversity from the pathogenic fungi Batrachochytrium dendrobatidis (Bd) and Batrachochytrium salamandrivorans (Bsal)

Environmental Impact Assessment for housing development

Press release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde

Evonik press release on the acquisition of Alkion BioPharma

Print out of Google Analytics for access to Phyre

OIE listing of Bsal

Atlas of Water Resources by Rio de Janeiro State Institute for the Environment

Study detailing the incidence of out-of-hospital cardiac arrest